Dott. Nicola Gasparetto

Dott. Nicola Gasparetto MD, PhD, FESC, FANMCO. Cardiologo Intensivista. Responsabile U.O.S. Terapia Intensiva Cardiologica
U.O.C.

Cardiologia, Dipartimento Neuro-Cardio-Vascolare, ULSS 2, Ospedale Ca' Foncello

Componente Area Management & Qualità ANMCO

14/07/2025

ICYMI: As obesity continues to drive CV risk, the ACC has released two 🆕 guidance documents to support clinicians: Concise Clinical Guidance on the medical management of obesity and a Scientific Statement focused on treating obesity in adults with . Both underscore the need for individualized, evidence-informed strategies that leverage emerging therapies and evolving clinical insights to reduce weight and improve cardiovascular outcomes. 🔗 https://bit.ly/40QH7ok

Plus, download the latest infographic supporting the ACC’s new Concise Clinical Guidance. 👇 Learn more: https://bit.ly/4emnSZG

30/06/2025

How much do beta blockers help after a heart attack — even when the heart’s pumping well? We revisit the origins of beta blockers in post-MI care, examine how evidence evolved, and explore the REDUCE-AMI trial, which questions whether beta blockers are still needed for all.

🎧 Listen to the latest episode of Beyond Journal Club, a collaboration between CORE IM and NEJM Group: https://nej.md/4ekdlxX

📖 Further reading
Original Article by T. Yndigegn et al.: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction https://nej.md/4akVhRx

ANMCO 2025. Momento di condivisione di importanti esperienze professionali.
18/05/2025

ANMCO 2025. Momento di condivisione di importanti esperienze professionali.

17/05/2025

Semaglutide (Wegovy) is associated with a 41% reduction in the risk for major adverse cardiovascular events (MACEs) within 6 months of initiation — well before patients achieve substantial weight loss or reach the full 2.4 mg weekly dose — according to new data from the SELECT trial. http://ms.spr.ly/6181SZq2T

13/04/2025

📌🗓️ 𝕊𝔸𝕍𝔼 𝕋ℍ𝔼 𝔻𝔸𝕋𝔼 ‼️
𝐖𝐄𝐁𝐈𝐍𝐀𝐑 𝐀𝐍𝐌𝐂𝐎
𝐌𝐚𝐫𝐭𝐞𝐝𝐢̀ 𝟏𝟓 𝐚𝐩𝐫𝐢𝐥𝐞 𝟐𝟎𝟐𝟓 𝐨𝐫𝐞 𝟏𝟕.𝟎𝟎 - 𝟏𝟖.𝟑𝟎
"𝐀𝐍𝐌𝐂𝐎 𝐃𝐨𝐜𝐮𝐦𝐞𝐧𝐭𝐬: 𝐓𝐚𝐬𝐭𝐢𝐧𝐠 𝐂𝐨𝐥𝐥𝐞𝐜𝐭𝐢𝐨𝐧 - 𝐏𝐨𝐬𝐢𝐭𝐢𝐨𝐧 𝐀𝐍𝐌𝐂𝐎 𝐬𝐮𝐥𝐥𝐚 𝐑𝐢𝐨𝐫𝐠𝐚𝐧𝐢𝐳𝐳𝐚𝐳𝐢𝐨𝐧𝐞 𝐟𝐮𝐧𝐳𝐢𝐨𝐧𝐚𝐥𝐞 𝐝𝐞𝐥𝐥𝐞 𝐔𝐓𝐈𝐂 𝐢𝐧 𝐈𝐭𝐚𝐥𝐢𝐚" 𝑎 𝑐𝑢𝑟𝑎 𝑑𝑒𝑙𝑙’𝐴𝑟𝑒𝑎 𝑀𝑎𝑛𝑎𝑔𝑒𝑚𝑒𝑛𝑡&𝑄𝑢𝑎𝑙𝑖𝑡𝑎̀ #𝐴𝑁𝑀𝐶𝑂
𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐚 𝐢𝐥 𝐩𝐫𝐨𝐠𝐫𝐚𝐦𝐦𝐚 👇
https://anmco.it/pages/formazione/webinar/i-webinar-anmco/anmco-documents-tasting-collection-position-anmco-riorganizzazione-funzionale-utic-italia

06/03/2025
27/12/2024

Artificial intelligence to enhance hemodynamic management in
🖥️ optimizing current hemodynamic monitoring
⚠️ predicting hemodynamic deterioration
🚦 classification or characterization of hemodynamic conditions
🛟 treatment support
⚙️ enhancing workforce efficiency
🔮 future perspectives
Free to read on Intensive Care Medicine
🔓 https://rdcu.be/d4Ewm

Indirizzo

Piazza Ospedale, 1
Treviso
31100

Telefono

+390422210703

Sito Web

Notifiche

Lasciando la tua email puoi essere il primo a sapere quando Dott. Nicola Gasparetto pubblica notizie e promozioni. Il tuo indirizzo email non verrà utilizzato per nessun altro scopo e potrai annullare l'iscrizione in qualsiasi momento.

Contatta Lo Studio

Invia un messaggio a Dott. Nicola Gasparetto:

Condividi

Digitare